These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 18789321

  • 1. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF, de Abreu Vieira PM, Arantes JM, Pedrosa ML, Martins HR, Silva M, Veloso VM, de Lana M, Bahia MT, Tafuri WL, Carneiro CM.
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [Abstract] [Full Text] [Related]

  • 2. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice.
    Arantes JM, Pedrosa ML, Martins HR, Veloso VM, de Lana M, Bahia MT, Tafuri WL, Carneiro CM.
    Exp Parasitol; 2007 Sep; 117(1):43-50. PubMed ID: 17521632
    [Abstract] [Full Text] [Related]

  • 3. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
    Arantes JM, Francisco AF, de Abreu Vieira PM, Silva M, Araújo MS, de Carvalho AT, Pedrosa ML, Carneiro CM, Tafuri WL, Martins-Filho OA, Elói-Santos SM.
    Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835
    [Abstract] [Full Text] [Related]

  • 4. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC, González Cappa SM, Solana ME.
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM, Martins TA, Caldas IS, Diniz LF, Machado-Coelho GL, Carneiro CM, Oliveira Rde P, Talvani A, Lana M, Bahia MT.
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G, Massago M, Kian D, Toledo MJO.
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML, Gazzinelli RT, Alves RO, Urbina JA, Romanha AJ.
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [Abstract] [Full Text] [Related]

  • 10. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
    Santos CD, Loria RM, Oliveira LG, Kuehn CC, Toldo MP, Albuquerque S, do Prado JC.
    Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
    [Abstract] [Full Text] [Related]

  • 11. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM.
    Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN, Eagleson MA, López-Muñoz RA, Solana ME, Altcheh J, García-Bournissen F.
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS, Silva TM, Milagre MM, Silva RR, Reis LES, Branquinho RT, Silva GN, de Lana M.
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM, Fernandes NS, Abegg CP, de Abreu AP, Sarto MPM, Gomes ML, Toledo MJO.
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [Abstract] [Full Text] [Related]

  • 18. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP, Massago M, Teston AP, Monteiro WM, Kaneshima EN, Araújo SM, Gomes ML, Barbosa Md, Toledo MJ.
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
    Batista Dda G, Batista MM, de Oliveira GM, Britto CC, Rodrigues AC, Stephens CE, Boykin DW, Soeiro Mde N.
    PLoS One; 2011 Jun; 6(7):e22155. PubMed ID: 21814568
    [Abstract] [Full Text] [Related]

  • 20. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
    Nogueira Silva JJ, Pavanelli WR, Gutierrez FR, Alves Lima FC, Ferreira da Silva AB, Santana Silva J, Wagner Franco D.
    J Med Chem; 2008 Jul 24; 51(14):4104-14. PubMed ID: 18570370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.